Weaknesses in the oversight of the 340 drug-pricing program may allow some hospitals to get discounts they are ineligible for, a newly released report from the Government Accountability Office found.
The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.
The drug giant says an Eighth Circuit ruling last year in a case from Minnesota should block a similar law in Missouri.
The Daily Overview on MSN
Court blocks Trump administration pilot drug rebate program
The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal ...
Six drugmakers who have violated the 340B statute should immediately begin offering drugs at discounted prices to hospitals participating in the federal drug-pricing program, according to a letter ...
The 340B drug discount program would work better if the money followed the patient rather than going directly to hospitals, Anthony DiGiorgio, DO, MHA, said Monday at an event on 340B sponsored by the ...
Commercial: Is the 340B Drug Pricing Program the Next 'Too Big to Fail'? WASHINGTON, Aug. 19, 2025 /PRNewswire/ -- ADAP Advocacy today, as part of its 340B Project, aired its latest commercial calling ...
Joe Grogan is a Nonresident Senior Scholar at the USC Schaeffer Institute and served as director of the White House Domestic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback